Latest Articles
Mocertatug Rezetecan Displays Early Efficacy, Tolerability in PROC and Endometrial Cancer - OncLive
Mocertatug Rezetecan Displays Early Efficacy, Tolerability in PROC and Endometrial Cancer OncLive
Published: April 12, 2026, 6:25 p.m.
Infigratinib shows promising efficacy and tolerability in pediatric achondroplasia - 2 Minute Medicine
Infigratinib shows promising efficacy and tolerability in pediatric achondroplasia 2 Minute Medicine
Published: March 11, 2025, 8:13 p.m.
Link copied to clipboard!